Modeling of Whole Genomic Sequencing Implementation using System Dynamics and Game Theory

10/02/2022
by   Marzieh Soltanolkottabi, et al.
0

Biomarker testing is a laboratory test in oncology that is used in the selection of targeted cancer treatments and helping to avoid ineffective treatments. There exist several types of biomarker tests that can be used to detect the presence of particular mutations or variation in gene expression. Whole Genome Sequencing (WGS) is a biomarker test for analyzing the entire genome. WGS can provide more comprehensive diagnostic information, but it is also more expensive than other tests. In this study, System Dynamics and Game Theoretic models are employed to evaluate scenarios, and facilitate organizational decision making regarding WGS implementation. These models evaluate the clinical and economic value of WGS as well as its affordability and accessibility. The evaluated scenarios have covered the timing of implementing WGS using time to diagnosis and total cost.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
12/20/2018

A Method to Facilitate Cancer Detection and Type Classification from Gene Expression Data using a Deep Autoencoder and Neural Network

With the increased affordability and availability of whole-genome sequen...
research
07/24/2023

Clustering MIC data through Bayesian mixture models: an application to detect M. Tuberculosis resistance mutations

Antimicrobial resistance is becoming a major threat to public health thr...
research
10/12/2021

SlideGraph+: Whole Slide Image Level Graphs to Predict HER2Status in Breast Cancer

Human epidermal growth factor receptor 2 (HER2) is an important prognost...
research
10/18/2019

The TCGA Meta-Dataset Clinical Benchmark

Machine learning is bringing a paradigm shift to healthcare by changing ...
research
05/21/2020

Using the "Hidden" Genome to Improve Classification of Cancer Types

It is increasingly common clinically for cancer specimens to be examined...
research
04/12/2013

Identifying cancer subtypes in glioblastoma by combining genomic, transcriptomic and epigenomic data

We present a nonparametric Bayesian method for disease subtype discovery...

Please sign up or login with your details

Forgot password? Click here to reset